PRODUCT DOSE OMISSION
Adverse reaction reported in 12,380 FDA reports across 14 drugs.
12,380
Total Reports
14
Drugs Involved
Apremilast
Most Reported Drug
Drugs Associated with PRODUCT DOSE OMISSION
Drugs where "PRODUCT DOSE OMISSION" was reported as an adverse event.
| # | Drug | Reports | % of Total |
|---|---|---|---|
| 1 | Apremilast | 4,594 | |
| 2 | Ruxolitinib | 1,373 | |
| 3 | Alirocumab | 1,364 | |
| 4 | Teriflunomide | 1,128 | |
| 5 | Belimumab | 651 | |
| 6 | Guselkumab | 569 | |
| 7 | Galcanezumab-Gnlm | 537 | |
| 8 | Umeclidinium Bromide / Vilanterol Trifenatate | 415 | |
| 9 | Droxidopa | 390 | |
| 10 | Mometasone Furoate / Formoterol Fumarate Dihydrate | 365 | |
| 11 | Rucaparib | 362 | |
| 12 | Patiromer | 321 | |
| 13 | Velpatasvir / Sofosbuvir | 184 | |
| 14 | Glecaprevir / Pibrentasvir | 127 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused product dose omission. Always consult your healthcare provider.